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Abstract
Satellite cells are tissue resident muscle stem cells required for postnatal skeletal muscle growth and repair through
replacement of damaged myofibers. Muscle regeneration is coordinated through different mechanisms, which
imply cell-cell and cell-matrix interactions as well as extracellular secreted factors. Cellular dynamics during muscle
regeneration are highly complex. Immune, fibrotic, vascular and myogenic cells appear with distinct temporal and
spatial kinetics after muscle injury. Three main phases have been identified in the process of muscle regeneration; a
destruction phase with the initial inflammatory response, a regeneration phase with activation and proliferation of
satellite cells and a remodeling phase with maturation of the regenerated myofibers. Whereas relatively minor
muscle injuries, such as strains, heal spontaneously, severe muscle injuries form fibrotic tissue that impairs muscle
function and lead to muscle contracture and chronic pain. Current therapeutic approaches have limited
effectiveness and optimal strategies for such lesions are not known yet. Various strategies, including growth factors
injections, transplantation of muscle stem cells in combination or not with biological scaffolds, anti-fibrotic
therapies and mechanical stimulation, may become therapeutic alternatives to improve functional muscle recovery.
Keywords: Skeletal muscle, Injury, Regeneration, Stem cell, Fibrosis, Scaffolds, Growth factors
Introduction
Human skeletal muscle is about 40 % of the body mass
and is formed by bundle of contractile multinucleated
muscle fibers, resulting from the fusion of myoblasts.
Satellite cells (SC) are skeletal muscle stem cell located
between the plasma membrane of myofibers and the
basal lamina. Their regenerative capabilities are essential
to repair skeletal muscle after injury (Hurme and Kalimo
1992; Lipton and Schultz 1979) (Sambasivan et al. 2011;
Dumont et al. 2015a). In adult muscles, SC are found in
a quiescent state and represent, depending on species,
age, muscle location, and muscle type, around 5 to 10 %
of skeletal muscle cells (Rocheteau et al. 2015). After in-
jury, SC become activated, proliferate and give rise to
myogenic precursor cells, known as myoblasts. After en-
tering the differentiation process, myoblasts form new
myotubes or fuse with damaged myofibers, ultimately
mature in functional myofibers.
Skeletal muscle injuries can stem from a variety of
events, including direct trauma such as muscle lacerations
and contusions, indirect insults such as strains and also
from degenerative diseases such as muscular dystrophies
(Huard et al. 2002; Kasemkijwattana et al. 2000; Kasemkij-
wattana et al. 1998; Menetrey et al. 2000; Menetrey et al.
1999; Crisco et al. 1994; Garrett et al. 1984; Lehto and Jar-
vinen 1991; Jarvinen et al. 2005; Cossu and Sampaolesi
2007). Skeletal muscle can regenerate completely and
spontaneously in response to minor injuries, such as
strain. In contrast, after severe injuries, muscle healing is
incomplete, often resulting in the formation of fibrotic tis-
sue that impairs muscle function. Although researchers
have extensively investigated various approaches to im-
prove muscle healing, there is still no gold standard
treatment.
This concise review provides a sight about the various
phases of muscle repair and regeneration, namely degen-
eration, inflammation, regeneration, remodeling and
maturation. We also give an overview of research efforts
that have focused on the use of stem cell therapy,
growth factors and/or biological scaffolds to improve
muscle regeneration and repair. We also address the
therapeutic potential of mechanical stimulation and of* Correspondence: thomas.laumonier@unige.ch
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Skeletal muscle has a robust innate capability for repair after
injury through the presence of adult muscle stem cells
known as satellite cells (SC). The disruption of muscle tissue
homeostasis, caused by injury, generates sequential involve-
ment of various players around three main phases (Fig. 1).
– (1, 2) Degeneration/inflammation phase:
characterized by rupture and necrosis of the
myofibers, formation of a hematoma and an
important inflammatory reaction.
– (3) Regeneration phase: phagocytosis of damaged
tissue, followed by myofibers regeneration, leading
to satellite cell activation.
– (4, 5) Remodeling phase: maturation of regenerated
myofibers with recovery of muscle functional capacity
(4) and also fibrosis and scar tissue formation (5).
Muscle degeneration and inflammation
Active muscle degeneration and inflammation occur
within the first few days after injury. The initial event is
necrosis of the muscle fibers, which is triggered by dis-
ruption of local homeostasis and particularly by unregu-
lated influx of calcium through sarcolemma lesions
(Tidball 2011). Excess in cytoplasmic calcium causes
proteases and hydrolases activation that contribute to
muscle damage and also causes activation of enzymes
that drive the production of mitogenic substances for
muscle and immune cells (Tidball 2005). After muscle
degeneration, neutrophils are the first inflammatory cells
infiltrating the lesion. A large number of pro-
inflammatory molecules such as cytokines (TNF-α, IL-
6), chemokine (CCL17, CCL2) and growth factors (FGF,
HGF, IGF-I, VEGF; TGF-β1) are secreted by neutrophils
in order to create a chemoattractive microenvironment
for other inflammatory cells such as monocytes and
macrophages (Tidball 1995; Toumi and Best 2003). Two
types of macrophages are identified during muscle re-
generation (McLennan 1996), which appear sequentially
Fig. 1 Sequential cycle of muscle healing phases after laceration. Histological images adapted from Menetrey et al, Am J Sports Med 1999. (sp:
superficial portion, de: deepest part)
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during muscle repair (Arnold et al. 2007). M1 macro-
phages, defined as pro-inflammatory macrophages, act
during the first few days after injury,. contribute to cell
lysis, removal of cellular debris and stimulate myoblast
proliferation. Conversely, M2 macrophages, defined as
anti-inflammatory macrophages, act 2 to 4 days after in-
jury, attenuate the inflammatory response and favor
muscle repair by promoting myotubes formation (Tidball
and Wehling-Henricks 2007; Chazaud 2014; Chazaud et
al. 2003). Macrophages, infiltrating injured muscle, are key
players of the healing process (Zhao et al. 2016), able to
participate in the muscle regeneration process or to favor
fibrosis (Munoz-Canoves and Serrano 2015; Lemos et al.
2015).
Muscle regeneration, remodeling and maturation
Muscle regeneration usually starts during the first 4–5
days after injury, peaks at 2 weeks, and then gradually
diminishes 3 to 4 weeks after injury. It’s a multiple steps
process including activation/proliferation of SC, repair
and maturation of damaged muscle fibers and connect-
ive tissue formation. A fine balance between these mech-
anisms is essential for a full recovery of the contractile
muscle function.
Muscle fibers are post-mitotic cells, which do not have
the capacity to divide. Following an injury, damaged
muscle fibers can’t be repaired without the presence of
adult muscle stem cells, the satellite cells (SC) (Relaix
and Zammit 2012; Sambasivan et al. 2011). Following
activation, SC proliferate and generate a population of
myoblasts that can either differentiate to repair damaged
fibers or, for a small proportion, self-renew to maintain
the SC pool for possible future demands of muscle re-
generation (Collins 2006; Dhawan and Rando 2005). SC
cycle progression and cell fate determination are control
by complex regulatory mechanisms in which, intrinsic
and extrinsic factors are involved (Dumont et al. 2015a;
Dumont et al. 2015b).
Connective tissue/fibrosis
Connective tissue remodeling is an important step of the
regenerative muscle process. Rapidly after muscle injury,
a gap is formed between damaged muscle fibers and
filled with a hematoma. Muscle injuries can be clinically
classified depending of the nature of the hematoma (size,
location). Late elimination of the hematoma is known to
delay skeletal muscle regeneration, to improve fibrosis
and to reduce biomechanical properties of the healing
muscle (Beiner et al. 1999). In rare complication, major
muscle injuries may lead to the development of myositis
ossificans that will impair muscle regeneration and re-
pair (Beiner and Jokl 2002) (Walczak et al. 2015).
The presence of fibrin and fibronectin at the injury
site, initiate the formation of an extracellular matrix that
is rapidly invaded by fibroblasts (Darby et al. 2016; Des-
mouliere and Gabbiani 1995). Fibrogenic cytokines such
as transforming growth factor β1 (TGF-β1) participate
to excessive fibroblasts/myofibroblasts proliferation and
to an increase in type I/III collagens, laminin and fibro-
nectin production (Lehto et al. 1985). In its initial phase,
the fibrotic response is beneficial, stabilizing the tissue
and acting as a scaffold for myofibers regeneration.
Nevertheless, an excessive collagen synthesis post injury,
often result in an increase of scar tissue size over time
that can prevent normal muscle function (Mann et al.
2011). Many growth factors are involved in the develop-
ment of fibrosis, such as Connective Tissue Growth Fac-
tor (CTGF), Platelet-Derived Growth Factor (PDGF) or
myostatin. TGF-β1, by stimulating fibroblasts/myofibro-
blasts to produce extracellular proteins such as fibronec-
tin and type I/III collagen, has been identified as the key
element in this process (Mann et al. 2011),. Although fi-
broblasts are the major collagen-producing cells in skel-
etal muscle, TGF-β1 have also an effect directly on
myoblasts causing their conversion to myofibroblasts.
Thus myoblasts initially acting to repair damaged myofi-
bers, will produce significant level of collagen and will
contribute to muscle fibrosis (Li and Huard 2002).
Revascularization
The restoration of the blood supply in the injured skeletal
muscle is one of the first signs of muscle regeneration and
is essential to its success. Without revascularization,
muscle regeneration is incomplete and a significant fibro-
sis occurs (Best et al. 2012; Ota et al. 2011). After muscle
trauma, blood vessels rupture induces tissue hypoxia at
the injury site (Jarvinen et al. 2005). New capillaries for-
mation quickly after injury is therefore necessary (Scholz
et al. 2003) for a functional muscle recovery. Secretion of
angiogenic factors such as vascular endothelial growth fac-
tor (VEGF) at the lesion site is important and several stud-
ies have shown that VEGF, by favoring angiogenesis,
improve skeletal muscle repair (Deasy et al. 2009; Frey et
al. 2012).
Innervation
Muscle repair is complete when injured myofibers are
fully regenerated and become innervated. The synaptic
contact between a motor neuron and its target muscle
fiber, often take place at a specific site in the central re-
gion of myofibers, the neuromuscular junction (NMJ)
(Wu et al. 2010). NMJ are essential for maturation and
functional activity of regenerating muscles. Within 2–3
weeks after muscle damage, the presence of newly
formed NMJ is observed in regenerative muscle (Rantanen
et al. 1995; Vaittinen et al. 2001).
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Strategies to improve muscle regeneration and repair
Growth factors
Growth factors play a variety of roles in the different
stages of muscle regeneration (Grounds 1999; Menetrey
et al. 2000). These biologically active molecules, synthe-
tized by the injured tissue or by other cell types present
at the inflammatory site, are release in the extracellular
space and modulate the regenerative response (Table 1).
Although hepatocyte growth factor (HGF), fibroblast
growth factor (FGF) and platelet-derived growth factor
(PDGF) are of interest because of their capacity to
stimulate satellite cells (Sheehan et al. 2000; Allen and
Boxhorn 1989; Yablonka-Reuveni et al. 1990), insulin
like growth factor-1 (IGF-I) appears to be of particular
importance for the muscle regeneration process. IGF-I
stimulates myoblasts proliferation and differentiation
(Engert et al. 1996) and is implicated in the regulation of
muscle growth (Schiaffino and Mammucari 2011). In a
mouse model, direct injections of human recombinant
IGF-I at two, five, and seven days after injury enhanced
muscle healing in lacerated, contused, and strain-injured
muscles (Menetrey et al. 2000; Kasemkijwattana et al.
2000). However, the efficacy of direct injection of recom-
binant proteins is limited by the high concentration of
Table 1 The role of growth factors in skeletal muscle regeneration
Growth
factors
Physiological effects, potential benefits Shortcomings Commentary
IGF-1 - Essential for muscle growth during
development and regeneration.
- Promote myoblast proliferation and
differentiation in vitro (Huard et al. 2002)
- Hypertrophic effect of IGF-1 (Barton-Davis
et al. 1999)
- Serial injections of IGF-1 improve muscle
healing in vivo (Menetrey et al. 2000).
- Existence of a muscle specific isoform of
IGF-1 (mIGF-1) (Musaro et al. 1999; Musaro
et al. 2004)
- Chemotactic for fibroblasts, increase
collagen production, enhance fibrosis
development
- IGF-1 play a central role in the
enhancement of muscle regeneration-
- Anti-inflammatory actions of IGF-1
(Mourkioti and Rosenthal 2005; Tidball
and Welc 2015)
HGF - Promote myoblast proliferation and inhibit
myoblast differentiation (Anderson 2016;
Yin et al. 2013)
- Important role for satellite cell activation.
Balance between the activation of satellite
cells and their return to quiescence.
(Chazaud 2010)
- Recently, it was shown that a second set of
HGF production is crucial for inflammation
resolution after injury (Proto et al. 2015)
- Injection of HGF into injured muscle
increased myoblast numbers but blocked
the regeneration process (Miller et al. 2000)
- HGF is important during the early phase
of muscle regeneration, activate
satellite cells
VEGF - Important signaling protein that favor
angiogenesis.
- Promote myoblast migration, proliferation
and survival. (Arsic et al. 2004)
- VEGF administration improves muscle
regeneration. (Messina et al. 2007; Deasy
et al. 2009)
- Non regulated VEGF expression promote
aberrant angiogenesis and fibrosis in
skeletal muscle (Karvinen et al. 2011)
- Importance of the proximity between
satellite cells and the microvasculature
during muscle
regeneration, role of VEGF
FGF - Large family of mitogen involved in cell
growth and survival
- FGF-6 has a muscle specific expression,
stimulates satellite cell proliferation and
promotes myogenic terminal differentiation
(Floss et al. 1997)
- FGF-2 promote satellite cell proliferation
and inhibit myogenic differentiation
(Menetrey et al. 2000; Kastner et al. 2000)
- Stimulate fibroblast proliferation, - FGF signaling plays a key role in muscle
repair, blocking FGF signaling delay
muscle regeneration (Saera-Vila et al. 2016).
TGF-β1 - Key regulator of the balance between muscle
fibrosis and muscle regeneration
- Inhibits satellite cell proliferation and
differentiation in vitro
- Excessive TGFβ1-induced deposition of
ECM at the site of injury, fibrosis (Garg
et al. 2015).
- Anti fibrotic therapy by blocking
overexpression of TGF-β1 improve muscle




- PDGF isoforms can regulate myoblast
proliferation and differentiation in vitro
(Yablonka-Reuveni et al. 1990)
- PDGF-BB stimulates satellite cell
proliferation and inhibit their differentiation
(Charge and Rudnicki 2004)
- Potent mitogen for fibroblasts - Release from injured vessels and platelets,
PDGF stimulates early skeletal muscle
regeneration
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the factor typically required to elicit a measurable effect.
This is mainly due to the bloodstream’s rapid clearance
of these molecules and their relatively short biological
half-lives. Gene therapy may be an effective method by
which to deliver high, maintainable concentrations of
growth factor to injured muscle (Barton-Davis et al.
1998; Barton et al. 2002; Musaro et al. 2001). Although
IGF-I improved muscle healing, histology of the injected
muscle revealed fibrosis within the lacerated site, despite
high level of IGF-I production (Lee et al. 2000). Another
growth factor, VEGF, by favoring angiogenesis, is known
to enhance skeletal muscle repair (Deasy et al. 2009; Frey
et al. 2012; Messina et al. 2007). By targeting simultan-
eously angiogenesis and myogenesis, it was shown that
combined delivery of VEGF and IGF-I enhance muscle
regenerative process (Borselli et al. 2010). In this direc-
tion, the use of platelet-rich plasma (PRP) is considered
as a possible alternative approach based on the ability of
autologous growth factors to improve skeletal muscle re-
generation (Hamid et al. 2014; Hammond et al. 2009).
Considered as safe products, autologous PRP injections
are increasingly used in patients with sports-related in-
juries (Engebretsen et al. 2010). Nevertheless, a recent
randomized clinical trial show no significant positive ef-
fects of PRP injections, as compared with placebo injec-
tions, in patients with muscle injuries, up to one year
after injections (Reurink et al. 2014; Reurink et al. 2015).
Customization of PRP preparation, as recently demon-
strated by the use of TGF-β1 neutralizing antibodies, is
a promising alternative to promote muscle regeneration
while significantly reducing fibrosis (Li et al. 2016).
Stem cells
Transplantation of satellite cell-derived myoblasts has
long been explored as a promising approach for treat-
ment of skeletal muscle disorders. After an initial dem-
onstration that normal myoblasts can restore dystrophin
expression in mdx mice (Partridge et al. 1989), clinical
trials, in which allogeneic normal human myoblasts were
injected intramuscularly several times in dystrophic
young boys muscles, have not been successful (Law et al.
1990; Mendell et al. 1995). Even recently, despite clear
improvement in methodologies that enhance the success
of myoblast transplantation in Duchenne patients (Skuk
et al. 2007), outcomes of clinical trials are still disap-
pointing. These experiments have raised concerns about
the limited migratory and proliferative capacities of hu-
man myoblasts, as well as their limited life span in vivo.
It led to the investigations of other muscle stem cells
sources that could overcome these limitations and out-
perform the success of muscle cell transplantation.
Among all these non-satellite myogenic stem cells,
human mesoangioblasts, human myogenic-endothelial
cells and human muscle–derived CD133+ have shown
myogenic potentials in vitro and in vivo (Sampaolesi et
al. 2006; Zheng et al. 2007; Meng et al. 2014). The use of
such myogenic progenitors cells for improving muscle
healing may become an interesting therapeutic alterna-
tive (Tedesco and Cossu 2012; Tedesco et al. 2010; Chen
et al. 2012). A first phase I/IIa clinical trial has recently
demonstrated that intra arterial injections of human
mesoangioblasts are safe but display only very limited
clinical efficacy in Duchenne patients (Cossu et al. 2015).
Scaffolds
Myogenic precursor cell survival and migration is greatly
increased by using appropriate scaffold composition and
growth factor delivery (Hill et al. 2006) (Boldrin et al.
2007). Controlling the microenvironment of injected
myogenic cells using biological scaffolds enhance muscle
regeneration (Borselli et al. 2011). Ideally, using an ap-
propriate extracellular matrix (ECM) composition and
stiffness, scaffolds should best replicate the in vivo mi-
lieu and mechanical microenvironment (Gilbert et al.
2010) (Engler et al. 2006). A combination of stem cells,
biomaterial-based scaffolds and growth factors may
provide a therapeutic option to improve regeneration
of injured skeletal muscles (Jeon and Elisseeff 2016).
Anti-fibrotic therapy
TGF-β1 is expressed at high levels and plays an import-
ant role in the fibrotic cascade that occurs after the on-
set of muscle injury (Bernasconi et al. 1995; Li et al.
2004). Therefore, neutralization of TGF-β1 expression in
injured skeletal muscle should inhibit the formation of
scar tissue. Indeed, the use of anti-fibrotic agents (ie dec-
orin, relaxin, antibody against TGF-β1…) that inactivate
TGF-β1 signaling pathways reduces muscle fibrosis and,
consequently, improve muscle healing, leading to a near
complete recovery of lacerated muscle (Fukushima et al.
2001; Li et al. 2007). Losartan, an angiotensin II receptor
antagonist, neutralize the effect of TGF-β1 and reduce
fibrosis, making it the treatment of choice, since it
already has FDA approval to be used clinically (Bedair et
al. 2008; Park et al. 2012; Terada et al. 2013). Suramin,
also approved by the FDA, blocks TGF-β1 pathway and
reduces muscle fibrosis in experimental model (Chan et
al. 2003; Taniguti et al. 2011).
Mechanical stimulation
Mechanical stimulation may offer a simple and effective
approach to enhance skeletal muscle regeneration. Stretch
activation, mechanical conditioning but also massage ther-
apy or physical manipulation of injured skeletal muscles
have shown multiple benefit effects on muscle biology and
function in vitro and in vivo (Tatsumi et al. 2001);(Best et
al. 2012) (Crane et al. 2012; Kumar et al. 2002; Gilbert et
al. 2010; Powell et al. 2002). Recently, Cezar and
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colleagues demonstrates that mechanical forces are as im-
portant biological regulators as chemicals and genes, and
underlines the immense potential of developing mechano-
therapies to treat muscle damage (Cezar et al. 2016). A re-
cent study also demonstrated that a treatment based on
ultrasound-guided intra-tissue percutaneous electrolysis
(EPI technique) enhances the treatment of muscle injuries
(Abat et al. 2015). Altogether, these results suggest that
mechanical stimulation should be considered as a possible
therapy to improve muscle regeneration and repair.
Conclusions
Skeletal muscle injuries are very frequently present in
sports medicine and pose challenging problems in trau-
matology. Despite their clinical importance, the optimal
rehabilitation strategies for treating these injuries are not
well defined. After a trauma, skeletal muscles have the
capacity to regenerate and repair in a complex and well-
coordinated response. This process required the pres-
ence of diverse cell populations, up and down-regulation
of various gene expressions and participation of multi-
ples growth factors. Strategies based on the combination
of stem cells, growth factors and biological scaffolds
have already shown promising results in animal models.
A better understanding of the cellular and molecular
pathways as well as a better definition of the interactions
(cell-cell and cell-matrix) that are essential for effective
muscle regeneration, should contribute to the develop-
ment of new therapies in humans. In this direction, a re-
cent paper from Sadtler et al demonstrated that specific
biological scaffold implanted in injured mice muscles
trigger a pro-regenerative immune response that stimu-
late skeletal muscle repair (Sadtler et al. 2016).
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